Simplified two-question screening for elevated Hospital Anxiety and Depression Scale (HADS) scores in orthopaedic patients: a retrospective cohort study with prospective validation

简化的两题筛查方法用于骨科患者医院焦虑抑郁量表(HADS)评分升高:一项回顾性队列研究及前瞻性验证

阅读:2

Abstract

OBJECTIVES: To assess whether it is possible to reduce the burden of completing the full Hospital Anxiety and Depression Scale (HADS) by identifying patients at risk for elevated HADS ≥11 using fewer questions. DESIGN: Retrospective cohort study followed by prospective validation. SETTING: A large Dutch hospital with orthopaedic patients. PARTICIPANTS: 13 345 orthopaedic patients with a median age of 53 years (IQR: 37-65) for the retrospective cohort; 100 patients for prospective validation. PRIMARY OUTCOME MEASURE: Incidence of HADS scores ≥11 and performance of a simplified screening model for elevated HADS. METHODS: The full HADS questionnaire consists of 14 items (7 each for anxiety and depression). Logistic regression models were developed retrospectively to predict HADS ≥11 using one or two questions. Models were evaluated based on sensitivity (>90%), negative predictive value (NPV >90%) and reduction of the response burden (>50%). The most effective model was validated prospectively in 100 patients. RESULTS: The retrospective cohort included 13 345 patients, with 20% (n=2671) having a HADS score ≥11. The final model, using questions 4 ('I can laugh and see the funny side of things') and 5 ('Worrying thoughts go through my mind'), achieved an area under the curve of 0.934, sensitivity of 95%, NPV of 98% and reduced the questionnaire burden by 57%. Prospective validation confirmed high sensitivity (94%) and NPV (98%) for identifying patients at risk of elevated HADS scores. CONCLUSIONS: In a large Dutch hospital, 20% of orthopaedic patients exhibited elevated HADS scores (≥11). Screening for elevated HADS using only two questions was highly effective, with significant reductions in patient burden. Patients who screen positive should complete the full HADS for accurate diagnosis and management. This approach could reduce the need for full HADS completion in over half of the patients, without sacrificing screening accuracy.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。